Jun 5 |
ArriVent Announces a Multi-Target ADC Collaboration with Alphamab
|
May 16 |
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
|
May 8 |
ArriVent BioPharma reports Q1 results
|
May 8 |
ArriVent BioPharma Reports First Quarter 2024 Financial Results
|
Apr 22 |
ArriVent Appoints Kristine Peterson to its Board of Directors
|
Mar 28 |
ArriVent BioPharma reports FY results
|
Mar 28 |
ArriVent BioPharma Reports Full Year 2023 Financial Results
|
Feb 2 |
$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying
|
Jan 29 |
ArriVent Wows Investors With Promising China-Developed Lung Cancer Treatment
|
Jan 22 |
ArriVent BioPharma upsizes proposed IPO to $150M from $100M
|